Medicine & Life Sciences
Amphotericin B
8%
Anti-Bacterial Agents
5%
Aspergillosis
36%
Aspergillus
5%
Aspergillus fumigatus
5%
Autoimmune Haemolytic Anaemia
32%
Autopsy
5%
Biofilms
11%
Bronchoalveolar Lavage
5%
Candida
100%
Candida albicans
61%
Candida glabrata
27%
Candida parapsilosis
12%
Candida tropicalis
13%
Candidiasis
36%
Causality
5%
Cell Survival
11%
Coinfection
23%
Colombia
78%
Control Groups
6%
Electron Scanning Microscopy
9%
Epidemiology
22%
Fluconazole
28%
Fungemia
11%
galactomannan
7%
Genetic Variation
23%
Growth
6%
Immunocompromised Host
5%
Immunosuppressive Agents
10%
In Vitro Techniques
13%
Indigenous Peoples
16%
Infections
24%
Invasive Candidiasis
46%
Invasive Fungal Infections
7%
Klebsiella pneumoniae
6%
Latin America
28%
lysyl-lysyl-leucyl-phenylalanyl-lysyl-lysyl-isoleucyl-leucyl-lysyl-tyrosyl-leucinamide
7%
Mortality
8%
Mycoses
9%
Patients' Rooms
6%
Peptides
46%
Pharmaceutical Preparations
6%
Public Health
9%
Pulmonary Tuberculosis
6%
Retrospective Studies
16%
Rhodotorula
12%
Ribosomal DNA
5%
Staphylococcal Pneumonia
8%
Therapeutic Uses
20%
Therapeutics
7%
Trichosporon
12%
Tuberculosis
20%
Vero Cells
15%
Voriconazole
6%
Yeasts
43%
Agriculture & Biology
adrenal cortex hormones
5%
amphotericin B
5%
animal models
21%
antibiotics
7%
antimicrobial peptides
27%
aspergillosis
34%
Aspergillus fumigatus
5%
Candida
53%
Candida albicans
17%
Candida glabrata
25%
Candida parapsilosis
17%
Candida tropicalis
15%
candidiasis
70%
cell viability
15%
cells
5%
central venous catheters
6%
Colombia
48%
comorbidity
9%
computed tomography
6%
diabetes mellitus
7%
drug therapy
9%
epidemiological studies
6%
epidemiology
26%
fungemia
14%
galactomannans
6%
genetic variation
15%
health services
6%
histopathology
8%
infection
23%
kidneys
5%
Latin America
28%
Meyerozyma guilliermondii
8%
mice
14%
microorganisms
5%
monitoring
6%
mycoses
6%
observational studies
6%
peptides
5%
rare species
8%
retrospective studies
31%
Rhodotorula
5%
Rhodotorula rubra
5%
ribosomal DNA
6%
scanning electron microscopy
6%
synthetic peptides
9%
therapeutics
18%
toxicity
5%
Trichosporon
5%
Trichosporon asahii
13%
yeasts
30%
Earth & Environmental Sciences
antibiotics
12%
blood
6%
cell
15%
chemotherapy
34%
consolidation
22%
diabetes
10%
DNA
6%
epidemiology
31%
genetic diversity
27%
health care
8%
histopathology
8%
hospital
46%
infection
70%
leukemia
5%
mortality
27%
neonate
5%
organ
22%
peptide
24%
risk factor
24%
serum
23%
surveillance
31%
tomography
21%
viability
11%
yeast
43%